248 related articles for article (PubMed ID: 3280154)
41. [Cytostatic chemotherapy of bronchial carcinoma].
Dold U; Engel J
Internist (Berl); 1970 Sep; 11(9):343-9. PubMed ID: 4921116
[No Abstract] [Full Text] [Related]
42. Cancer chemotherapeutic agents.
Oswalt CE; Cruz AB
Tex Med; 1977 May; 73(5):57-67. PubMed ID: 860280
[No Abstract] [Full Text] [Related]
43. Effectiveness of clinically active antineoplastic drugs in a surgical-adjuvant chemotherapy treatment regimen using the Lewis Lung (LL) carcinoma.
Merker PC; Wodinsky I; Cantor ML; Venditti JM
Int J Cancer; 1978 Apr; 21(4):482-9. PubMed ID: 78911
[No Abstract] [Full Text] [Related]
44. New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Saijo N
Chest; 1998 Jan; 113(1 Suppl):17S-23S. PubMed ID: 9438685
[TBL] [Abstract][Full Text] [Related]
45. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
Goa KL; Faulds D
Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
[TBL] [Abstract][Full Text] [Related]
46. Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.
Muggia FM; Blum RH; Foreman JD
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):137-45. PubMed ID: 6365863
[TBL] [Abstract][Full Text] [Related]
47. Cancer chemotherapy. Current status, coming innovations.
Neilan BA
Postgrad Med; 1983 Jan; 73(1):125-30. PubMed ID: 6336838
[TBL] [Abstract][Full Text] [Related]
48. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules.
Lam WK; So SY; Kung TM; Sham MK; Ip M
Cancer Chemother Pharmacol; 1987; 19(3):269-71. PubMed ID: 3107849
[TBL] [Abstract][Full Text] [Related]
49. Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.
Edwards MS; Levin VA; Wilson CB
Cancer Treat Rep; 1980; 64(12):1179-205. PubMed ID: 7008937
[TBL] [Abstract][Full Text] [Related]
50. EC145: a novel targeted agent for adenocarcinoma of the lung.
Pribble P; Edelman MJ
Expert Opin Investig Drugs; 2012 May; 21(5):755-61. PubMed ID: 22462761
[TBL] [Abstract][Full Text] [Related]
51. A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer.
Luedke DW; Luedke SL; Petruska P; Broun GO; Leavitt J; Schlueter J
Cancer; 1983 Mar; 51(5):778-82. PubMed ID: 6336984
[TBL] [Abstract][Full Text] [Related]
52. [Current trends in the chemotherapy of cancer].
Silva-Sosa M
Gac Med Mex; 1974 May; 107(5):469-87. PubMed ID: 4602758
[No Abstract] [Full Text] [Related]
53. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
Kelsen D
Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
[TBL] [Abstract][Full Text] [Related]
54. [Use of cytostatic drugs in therapy and research].
Wie H
Tidsskr Nor Laegeforen; 1973 Mar; 93(7):443-9. PubMed ID: 4699142
[No Abstract] [Full Text] [Related]
55. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
Hribaschek A; Pross M; Ridwelski K; Meyer F; Fenske A; Krüger S; Lippert H
Zentralbl Chir; 2004 Aug; 129(4):328-34. PubMed ID: 15354258
[TBL] [Abstract][Full Text] [Related]
56. [Anticancer chemotherapy. Prescription in the presence of renal insufficiency].
Moulin B; Fillastre JP; Godin M; Chantrel F
Nephrologie; 1995; 16(3):233-8. PubMed ID: 7783831
[No Abstract] [Full Text] [Related]
57. [Research results and prospects in the field of experimental leukemia chemotherapy].
Kozinets GI; Khomchenovskiĭ EI; Reshchikov VP; Khanykova OK; Egorov LV
Probl Gematol Pereliv Krovi; 1979 Jan; 24(1):3-7. PubMed ID: 368760
[No Abstract] [Full Text] [Related]
58. Chemotherapy of inoperable malignancy.
Fennelly JJ
Br J Surg; 1967 Oct; 54(10):819-24. PubMed ID: 4167308
[No Abstract] [Full Text] [Related]
59. [Specific histotropism of antineoplastic agents].
Berti T
Clin Ter; 1970 Nov; 55(4):293-303. PubMed ID: 4930868
[No Abstract] [Full Text] [Related]
60. Phase III trial with and without lonidamine in non-small cell lung cancer.
Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
